Eva Medtec, with a valuation of $11,030,000, is raising funds on Startengine. They make it possible for anyone to experience the benefits of automated lymphatic therapy with one simple, at-home system. Eva Medtec is targeting the $4B Pain Management Devices market. They have created and manufactured Neuroglide™, an over the counter, FDA-cleared medical device engineered to automate and emulate manual lymphatic drainage (MLD) therapy. Irene Waldridge founded Eva Medtec in 2016. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,234,999. The campaign proceeds will be used for company employment, inventory, working capital and clinical studies.